KLK3 and prostate cancer: The prostate cancer data is used as a case study and we have demonstrated that the model combining genotype information with phenotypes yields a better performance than using only genotype or phenotype data in disease diagnosis while also exceeding the performance of prostate specific antigen (PSA) screening test [23].